Related Experiment Videos
Metastases from transitional cell carcinoma of urinary bladder
Urology
|August 1, 1980
Summary
Metastatic transitional cell carcinoma commonly spreads to lymph nodes, liver, lungs, bone, and adrenal glands. High-grade tumors warrant early, aggressive treatment for better survival outcomes.
Area of Science:
- Oncology
- Pathology
Background:
- Transitional cell carcinoma (TCC) is a significant cause of cancer mortality.
- Understanding metastatic patterns and survival is crucial for treatment strategies.
Purpose of the Study:
- To investigate the common sites of metastasis in patients with transitional cell carcinoma.
- To analyze the clinical presentation, timing of metastasis, and survival duration.
- To correlate tumor grade with clinical presentation and prognosis.
Main Methods:
- Retrospective analysis of necropsy findings in 107 patients with metastatic TCC.
- Clinical data review for metastasis documentation and survival timelines.
Main Results:
- Common metastatic sites included lymph nodes, liver, lung, bone, and adrenal glands.
- One-third of patients presented with multiple metastatic sites clinically.
- Mean survival was 13 months from primary diagnosis; death occurred within 3 months of metastasis detection.
- Most patients presented with high-grade tumors.
Conclusions:
- Metastatic TCC frequently involves multiple organs.
- Early detection of high-grade tumors is critical.
- Aggressive therapy is recommended for high-grade TCC, irrespective of clinical stage.